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Abstract: Honey is a natural substance appreciated for its therapeutic abilities since ancient times.
Its content in flavonoids and phenolic acids plays a key role on human health, thanks to the high
antioxidant and anti-inflammatory properties that they exert. Honey possesses antimicrobial capacity
and anticancer activity against different types of tumors, acting on different molecular pathways that
are involved on cellular proliferation. In addition, an antidiabetic activity has also been highlighted,
with the reduction of glucose, fructosamine, and glycosylated hemoglobin serum concentration.
Honey exerts also a protective effect in the cardiovascular system, where it mainly prevents the
oxidation of low-density lipoproteins, in the nervous system, in the respiratory system against
asthma and bacterial infections, and in the gastrointestinal system. A beneficial effect of honey can
also be demonstrated in athletes. The purpose of this review is to summarize and update the current
information regarding the role of honey in health and diseases.
Keywords: honey; antioxidants; polyphenols; antimicrobial activities; cancer; diabetes; disease prevention
1. Introduction
Oxidative stress is the basis of structural and functional damage to the main biomolecules such as
nucleic acids, lipids, and proteins. In fact, these injuries lead to the development of many diseases,
such as cancer, metabolic disorders, and cardiovascular dysfunctions. The imbalance created between
the production of free radicals and antioxidant defense can occur not only in pathological situations,
but also in some physiological conditions such as intense physical activity [1]. Exogenous intake of
antioxidant compounds through the diet can counteract the effect of oxidant molecules such as free
radicals, reducing oxidant stress [2]. Honey is a natural substance that bees produce from honeydew or
nectar of flowers. Bees collect nectar or honeydew, and transport them into the hive, which begins the
processes that lead to their transformation into honey: the concentration and the enzymatic conversion
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of sugar. Honey composition is closely related to its botanical origin, and to the processing and
environmental conditions [3].
Since ancient times, honey has been not only considered a food or a sweetener, but it was also used
as a medicine for stimulating healing of wound, tissue regeneration, and alleviating gastrointestinal
disorders, gingivitis, and various other pathologies. The therapeutic effect of honey results from
the presence of various antioxidant molecules, including phenolic compounds, such as flavonoids
and phenolic acids [4]. Several in vitro and in vivo studies have demonstrated the antimicrobial,
antiviral, antifungal, anticancer, and antidiabetic activity of honey. In addition, the protective effect
on cardiovascular, nervous, respiratory, and gastrointestinal systems has been also proven [5,6].
A protective effect of honey was also observed in physiological condition characterized by high levels
of free radicals, such as those of athletes practicing different sports [7] (Figure 1).
Figure 1. Beneficial effect of honey consumption.
The effect of honey on human health depends on the bioavailability of the phytochemical
compounds, and on their methods of absorption and metabolization. The aim of the present review is
to summarize and update recent evidence, obtained from in vitro and in vivo studies, on the potential
of honey in maintaining human well-being, and preventing the most common diseases.
2. Chemical and Phytochemical Composition
Honey contains about 180 types of different compounds, including water, sugars, free amino
acids, proteins, enzymes, essential minerals, vitamins, and various phytochemicals (Table 1) [8].
The composition, taste and color of the different honey depend on the type of flower source,
the geographical area, the climate, and the different species of bees involved in honey production,
which is also conditioned by the processing techniques and storage [9].
Table 1. Chemical composition of the most commonly consumed types of honey. Adapted from
Escuredo et al.
Component Amount in 100 g of Honey
Water 16.9–18 g
Carbohydrates (total) 64.9–73.1 g
Fructose 35.6–41.8 g
Glucose 25.4–28.1 g
Maltose 1.8–2.7 g
Sucrose 0.23–1.21 g
Proteins, vitamins, amino acid and minerals 0.50–1 g
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2.1. Nutrients
Honey is an important source of macro- and micronutrients. Carbohydrates, mono- and
disaccharides, comprise 95% of its dry weight: glucose and fructose are present in larger quantities,
and they contribute principally to the energetic value and physical characteristics of honey, such as
hygroscopicity, granulation, and viscosity. The concentration of glucose and fructose and the
relationship between them is one of the main classification parameters in monofloral honeys. Among
carbohydrates, maltose, sucrose, turanose, isomaltose, cellobiose, isopanose, and many others in
different quantities can be also found [10].
The disaccharides and trisaccharides present in honey are hydrolyzed into monosaccharides from
different types of enzymes, such as invertases and α-glucosidases [11]. These sugars are subjected
to chemical changes during honey storage: a long or wrong conservation can lead to the formation
of undesirable compounds derived from pentoses (furfural) and hexoses (5-hydroxymethylfurfural
(5-HMF)). Usually these products derive from the Maillard reaction, and they are used to test the
quality of honey, indicating a possible exposure to high temperatures or a prolonged storage time [12].
Minor amounts of proteins are present, mainly in the form of enzymes and free amino acids,
except for asparagine and glutamine. Proline is the main amino acid in honey (50–85%), resulting
primarily from the salivary secretions of honeybees (Apis mellifera L.); it is used as a parameter to
evaluate the degree of honey maturation. Other amino acids are alanine, phenylalanine, tyrosine,
glutamic acid, isoleucine, and leucine [13].
In honey, there is also a variable amount of essential minerals (about 0.2% of its dry weight),
which varies according to its botanical origin, environmental conditions and processing. Among the
most represented minerals, potassium, calcium, copper, iron, magnesium, manganese, phosphorus,
sodium, zinc and selenium can be found. Honey also contains small amounts of vitamins, such as
ascorbic acid (C), thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), and pyridoxine
(B6) [5]. All the vitamins of the complex B derive mainly from pollen, and together with vitamin
C, it can be influenced by commercial and industrial processes, such as filtration and by oxidation
reactions carried out by glucose oxidase [14].
2.2. Enzymes and Organic Acids
A portion of proteins present in the honey consists essentially of enzymes derived from pollen,
nectar, and bees. The main enzymes are diastase, glucose oxidase, and invertase. Diastases are
amylolytic enzymes, such as α-amylases that hydrolyse the chains of starch producing dextrin and
β-amylases that lead to maltose formation, and whose activity is an important factor for honey’s
quality. Glucose oxidase converts glucose into δ-gluconolactone, which is hydrolyzed to gluconic acid,
the principal acid in honey and hydrogen peroxide (H2O2), responsible of the antimicrobial activity of
honey. The invertase has the ability to hydrolyse sucrose in glucose and fructose [15].
All types of honey have some acidity, because of the presence, although low, of organic acids;
these acids contribute both to the honey flavor and to its antimicrobial activity, as well as to the stability
of this food matrix. The most important is gluconic acid, followed by aspartic acid, citric, acetic, formic,
fumaric, galacturonic, malonic, formic, acetoglutaric, gluconic, glutamic, butyric, glutaric, butyric,
shikimic, propionic, pyruvic glyoxylic, 2-hydroxybutyric, α-hydroxyglutaric, isocitric, lactic, malic,
methylmalonic, quinic, succinic, tartaric, oxalic and others [16].
2.3. Phenolic Compounds
Polyphenols are a heterogeneous class of chemical compounds that can be divided into
flavonoids (flavonols, flavones, flavanols, flavanones, anthocyanidin, chalcones, and isoflavones)
and non-flavonoids (phenolic acids). All these compounds are often the product of secondary plant
metabolism and are characterized by the presence of multiple phenolic groups that are associated
with more or less complex structures. The secondary metabolites differ from the primary (chlorophyll,
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amino acids, and simple carbohydrates) because, although they have important ecological functions,
they do not mediate in the processes of assimilation, respiration, transport, and differentiation of
the plants. The phenolic composition in honey mainly depends on its floral origin; in fact, it can
be used as a tool for classification and authentication, especially in the case of unifloral varieties.
The most common phenolic compounds in honey are shown in Figure 2, and in Table 2, it is possible
to compare the phenolic compounds identified in the different types of honey that are mentioned in
this review [17–28].
Figure 2. Most common phenolic compounds identified in honey.
Table 2. Common phenolic acids and flavonoids in honeys.
Presence of Phenolic Compounds in Different Honeys
Flavonoids
Apigenin C15H10O5 AH, TH, STH
Catechin C15H14O6 TH, PH
Chrysin C15H10O4 MH, AH, TH, HH, THH, RH
Galangin C15H10O5 MH, AH, STH, HH
Genistein C15H10O5 AH
Isorhamnetin C16H12O7 MH
Kaempferol C15H10O6 MH, AH, TH, STH, THH, RH
Luteolin C15H10O6 MH, AH, TH, STH, THH, RH
Myricetin C15H10O8 AH, HH, THH
Pinobanksin C15H12O5 MH, AH, STH, RH
Pinocembrin C15H12O4 MH, AH, STH, RH
Quercetin C15H10O7 MH, AH, CH, THH
Rutin C27H30O16 STH
Phenolic Acids
2-cis,4-trans Abscisic acid C15H20O4 STH
2-Hydroxycinnamic acid C9H8O3 TH
Caffeic acid C9H8O4 MH, AH, TH, THH
Chlorogenic acid C16H18O9 AH, HH, THH
Cinnamic acid C9H8O2 TH, STH, CH, HH, THH
Ellagic acid C14H6O8 HH
Ferulic acid C10H10O4 MH, AH, HH, THH
Gallic acid C7H6O5 MH, AH, TH, HH, THH, PH
p-Coumaric acid C9H8O3 MH, AH, TH, HH, THH, RH, PH
p-Hydroxybenzoic acid C7H6O3 CH, HH
Protocatechuic acid C7H6O4 HH, PH
Sinapic acid C11H12O5 HH
Syringic acid C9H10O5 MH, AH, TH, STH, HH, THH
Vanillic acid C8H8O4 AH, HH
Manuka Honey (MH); Acacia Honey (AH); Tualang Honey (TH); Strawberry Tree Honey (STH); Clover Honey
(CH); Heather Honey (HH); Thyme Honey (THH); Rosemary Honey (RH); Pine Honey.
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These substances have been recognized as the main responsible for the antioxidant activity of
honey that is mainly associated with the ability of free radical scavengers, through the formation of
more stable and less toxic molecules. Phenolic compounds stabilize free radicals when they give off
hydrogen from one of their hydroxyl group; the degree of activity is related to the number of their
hydroxyl groups [29].
The flavonoids are natural chemical compounds with low molecular weight, and they are mainly
water-soluble. They are formed by two benzene rings, alternated by a linear chain of three atoms
of carbon (C6-C3-C6); this structure often rearranges itself to form three rings with 15 carbon atoms
called A, B and C (Figure 3). Generally these compounds have at least two phenolic groups (OH),
and are often associated with sugars (glycosides), mainly glucose together with xylose, galactose,
rhamnose, arabinose, rutinoside and glucorhamnose; when flavonoids are not associated with sugars
they are called aglycones. The flavonoids are then classified according to the degree of oxidation
of the C ring in: flavanols, flavones, flavanonols, flavonols, flavanones, isoflavones, anthocyanins,
and anthocyanidins. The most abundant ones in honey are flavones, flavanols, and flavonols [30].
Figure 3. Basic flavonoid structure.
Phenolic acids (phenol carboxylic acid) contain a phenolic ring and at least one organic carboxylic
acid function; they can be divided according to their structure: C6-C3 (e.g., p-coumaric, ferulic and
caffeic acid), C6-C2 (e.g., acetophenones and phenylacetic acids) and C6-C1 structure (e.g., syringic,
vanillic and gallic acid). Usually, most of these compounds are bound to the structural components of
the plant (cellulose, lignin), but also to other types of organic molecules such as glucose, other sugars,
or flavonoids [31].
3. Metabolism and Bioavailability of Honey Polyphenols
As mentioned previously, the beneficial effect of honey on human health derives mainly from
its content in phenolic compounds. To understand the effects that these phenolic compounds have,
it is appropriate to evaluate their absorption and metabolism. There are several factors that can
influence the bioavailability of dietary polyphenols, such as environmental factors, food processing,
type of matrix, interaction with other compounds (proteins or other polyphenols), the chemical
structure of the phenolic compounds, and intestinal factors (composition of microflora). There is
no explanation of the process of absorption, metabolism and excretion that is valid for all phenolic
compounds [32]. There are studies that have been performed both in vitro and in vivo to try to
understand the mechanisms behind the bioavailability of these compounds [33]; only a few studies
have specifically investigated the polyphenols derived from honey. One of these studies examined
the total amount of polyphenols after honey ingestion in plasma, and it found a minimal quantity
compared to that present in honey, demonstrating a very low bioavailability and absorption [34].
Most of the studies on phenol metabolism are on flavonoids. A first phase of flavonoid metabolism
concerns the hydrolysis reaction that can be performed both by bacterial enzymes present in the
intestine, and by two kinds of enzymes present in the small intestine. The β-hydrolysis of the sugar in
the glycosylated flavonoids can be in fact catalyzed by two β-endoglucosidases: the lactase phlorizin
hydrolase (LPH) and the cytosolic β-glucosidase (CBG) [35]. When LPH, which is found in the brush
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border of the enterocytes, catalyzes the hydrolytic reaction, the released aglycone can enter more easily
to the epithelial cells, due to increased lipophilicity. When the hydrolysis reaction is catalyzed by CBG,
the polar glucosides are transported inside the epithelial cells through a sodium-dependent glucose
transporter 1 (SGLT1), where they are hydrolyzed [36]. Some studies have shown that some flavonoids
can inhibit Na-dependent facilitated diffusion of monosaccharides into intestinal epithelial cells [37].
Regarding honey and its flavonoids, they must be taken into account that in this matrix,
there are some glucosidases deriving from the salivary glands of bees which could be a further
hydrolysis pathway of these compounds, and an explanation to the fact that many flavonoids
are found in honey as aglycones. Phenolic aglycones are more easily absorbed by intestinal
barriers, increasing their bioavailability, if compared with the same flavonoids glycosylated present
in different food matrix [38]. Once absorbed by the intestinal epithelium and before arriving
inside the bloodstream, the flavonoids enter the second phase of the metabolism, which leads to
the formation of different conjugated products: in particular, sulfotransferases (SULTs) generate
sulfates, uridine-5′-diphosphate glucuronosyltransferases (UGTs) allows the formation of glucoronides,
the catechol-O-methyltransferases (COMTs) produce methylated derivatives. In addition to these
metabolic biotransformations that affect the absorption, the bioavailability and the distribution of
flavonoids at the cellular and tissue levels are also mediated by some proteins that are associated with
multi-resistance (MRP1, MRP2), which are part of the third phase of the metabolism of flavonoids [39].
MRP2 is located in the apical membrane of the epithelial cells of the small intestine, and it
transports flavonoids back into the intestinal lumen. MRP1 is located in the vascular pole of the
enterocytes, and promotes the transport of flavonoids inside the blood cells [40]. Also, MRP3 and the
glucose transporter (GLUT2) aid in the transport of these compounds in the portal venous system;
once they enter the latter, the metabolites quickly reach the hepatocytes, where the aglycones are
transferred in the peroxisomes and in the Golgi apparatus, where they are subjected to further metabolic
processes [41].
Some flavonoids contain sugars that are resistant to the action of LPH and CBG, so that they
are not absorbed by the small intestine, and they pass directly into the colon where they can be
deglycosylated by enterobacteria present in this district. The microflora of the colon also transforms
the aglycones into various metabolites that can either be excreted from the feces, or be absorbed by the
liver within the enteropathic recirculation of the bile excretion and be further conjugated by specific
enzymes as previously explained [42]. Other metabolites, however, after the metabolic changes that
occur in the hepatocytes are secreted by some organic acid transporters in the systemic circulation,
and they are either absorbed by cells or tissues or expelled by the kidneys [43].
4. Oxidative Stress, Antioxidant Activity, and Inflammation
Oxidative stress can be defined as an imbalance between oxidants and antioxidants in favor of
oxidants. Oxidative stress produces oxidative damage that can affect various physiological functions.
Free radicals and reactive oxygen species (ROS) are the major oxidant agents in cellular systems,
and they are involved in aging and in the onset of many kind of diseases [44].
ROS and free radicals are physiologically produced in different cellular biochemical reactions
that occur in the body, such as in mitochondria for the aerobic production of oxygen [45], in the
metabolism of fatty acids [46], in the metabolization of drugs [47], and during the activity of the
immune system [48]. On the other hands, free radicals can also be produced by exogenous factors such
as pollution, incorrect life habits, UV rays, ionizing radiation, and psychophysical stress from intense
physical activity [49]. Antioxidants are molecules that are able to donate an electron to free radicals,
neutralizing, decreasing, or eliminating their ability to damage cells and major biomolecules such as
nucleic acids, proteins, and lipids [50].
Antioxidants can be endogenous (superoxide dismutase (SOD), alpha lipoic acid (ALA), catalase,
coenzyme Q10 (CoQ10), glutathione peroxidase (GPX)) or exogenous, which are taken through the
diet. The antioxidant capacity (AOC) is considered to be an indicator of the presence of bioactive
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compounds in honey. The AOC of honey is given primarily by phenolic compounds, but enzymes,
amino acids, and carotenoids also contribute to this ability. Radical scavenging and protection against
the lipid peroxidation of honey can reduce and prevent diseases and physiological situations where
oxidative stress plays an important role [51].
In recent years, it has emerged that oxidative stress plays a fundamental role in the development
and propagation of a state of inflammation, leading to the onset of various diseases [52]. Both
processes have often been found simultaneously in subjects with diabetes, cancer, cardiovascular,
neurodegenerative disorders, and many other disease situations [53].
5. Honey and Health and Diseases
5.1. Antimicrobial, Antiviral, and Antifungal Activity
The use of honey as antimicrobial is known since ancient times. There are several studies
regarding the antibacterial activity of honey (Table 3) [54], which seems to act on both Gram-positive
and Gram-negative, although the first are more sensitive. All the studies, summarized in the Table 3
were done using the agar disk-diffusion test and evaluating the minimum inhibitory concentration
(MIC), and the minimum bactericidal concentration (MBC) of different types of honey with diverse
bacterial agents. In general, monofloral honey has a greater antibacterial effect than multifloral
honey [55]. This ability is mainly due to some physical properties of this matrix, such as low water
activity (Aw), high osmotic pressure, low pH, and low protein content, which prevent bacterial
growth. In addition to these physical properties, the antimicrobial activity of honey is also due to the
glucose oxidase, H2O2, and to some phenolic compounds such as pinocembrin, syringic acid, and
some others compounds [56]. Recent studies are focusing on the presence and role of metylglyoxal
(CH3-CO-CH=O), especially in Manuka honey (Leptospermum scoparium), since it is believed to be the
most responsible for the non-peroxide antibacterial activity of honey [57].
Table 3. Some examples of antimicrobial activity of honey.
Bacterial Strain Clinical Importance
Helicobacter pylori Peptic ulcer, gastric malignancies, chronic gastritis
Pseudomonas aeruginosa Diabetic foot ulcer, wound infection, urinary infections
Escherichia coli Urinary tract infection, diarrhea, septicemia, wound infections
Mycobacterium tuberculosis Tuberculosis
Staphylococcus aureus Community acquired and nosocomial infection
Proteus spp. Septicemia, urinary infections, wound infections
Salmonella enterica Enteric fever
Acinetobacter baumannii Infection through open wounds, catheters, and breathing tubes
Vibrio cholerae Cholera
An activity closely linked to antibacterial capacity is wound healing. The ability of honey to
sterilize the wounds, stimulate tissue re-growth, and to reduce edema and scar formation, affects
simple wounds, burns, diabetic foot ulcers, and pressure ulcers [6,58,59].
Some studies have also shown a certain antiviral activity of honey. It was evaluated that the
in vitro effect of Manuka and Clover honey in human malignant melanoma cells (MeWo)-infected
with varicella Zoster virus (VZV) isolated from a Zoster vesicle. The results showed a reduction of
the viral plaques after the treatment of the cells with both types of honey [60]. A similar effect has
also been proven in Madin-Darby canine kidney (MDCK) cells infected with influenza virus (H1N1),
treated with different types of honey (Manuka, renge, and Acacia honey). The plaque inhibition assay
has been carried out showing a higher antiviral activity of Manuka honey, compared to the other types
of honey, and the synergistic effects with some antiviral drugs [61].
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It has also been demonstrated an antifungal activity of honey towards different kinds of Candida
infections (C. albicans, C. glabrata, and C. dubliniensis), and on Rhodotorula sp., evaluating the MIC and
using the agar disk-diffusion test [62,63].
Finally, the high antimicrobial capacity of honey is also closely linked to the improvement of the
gut microbial balance, thanks to the high content of oligosaccharides, which act as a substrate for the
growth of prebiotic microorganisms. One study has reported the potential of honey to Lactobacilli and
Bifidobacteria: the vitality and the growth rate of these essential microorganisms in the balance of the
gut microbiota increased with the addition of different types of honey [64].
5.2. Anticancer Activity
The potential effects of honey on cancer have been investigated both in terms of prevention,
and progression and treatment. Most of the studies are in vitro, and they have been carried out on
different types of cell lines and different types of honey. Some studies have also been carried out
in vivo on mice/rats, inducing or transplanting the tumor [65].
Honey acts at different stages of cancer, on the initiation, proliferation, and progression.
Its antitumoral effects are generally attributed to different mechanisms, such as the induction of
apoptosis, cell cycle arrest, the modulation of oxidative stress, the amelioration of inflammation,
the induction of mitochondrial outer membrane permeabilization (MOMP), and the inhibition of
angiogenesis [66] (Figure 4).
Figure 4. Molecular mechanism involved in anticancer effect of honey.
Apoptosis is a programmed cell death process that eliminates damaged cells. Through the
up-regulation of some proapoptotic proteins, such as caspase 3, 8, 9, Bax, p53, and the down-regulation
of other antiapoptotic proteins, such as Bcl2 and poly (ADP-ribose) polymerase (PARP), honey is
considered a good inducer of apoptosis. Another mechanism for honey in acting against cancer cells
is the arrest of the cell cycle, by modulation of some molecules, such as cyclooxygenase and some
kinases, or the induction of MOMP, promoted especially by flavonoids, which cause the release of
intramembrane proteins into the cytosol, resulting in cell death. Indeed, the permeabilization of
mitochondrial membrane is an early event that leads to the activation of the intrinsic mitochondrial
pathway, which induces several processes, including the release of certain proteins such as cytochrome
C (cytC), potentially cytotoxic, causing cell death [67].
The role of ROS and oxidative stress in cancer is still controversial, since it is unknown if it has
a stimulatory or inhibitory effect. However, it would appear that the inhibition of tumor growth is still
linked to the antioxidant properties of honey [68].
Finally, honey is able to counteract chronic inflammatory processes, which increase the risk of
cancer. Two important factors of inflammatory pathway in cancer are nuclear factor kappa B (NF-kB)
and mitogen-activated protein kinase (MAPK), which are involved in the up-regulation of some
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pro-inflammatory mediators such as interleukin 1 (IL-1), IL-6, and TNF-α [69], and some inflammatory
proteins such as C-reactive protein (CRP), cyclooxygenase-2 (COX-2), and lipoxygenase-2 (LOX-2),
playing an important role, not only in inflammation, but also in angiogenesis, a fundamental process
of tumorigenesis [70].
Fauzi et al. investigated the effect of Tualang honey in breast (MCF-7 and MDA-MB-231) and
cervical (HeLa) cancer cell lines, founding a cytotoxic effect, mainly due to a reduction of mitochondrial
membrane potential, and to the activation of pro-apoptotic proteins such as caspase 3 and 9 [71].
Another study has also been carried out in vivo, investigating the effect of Manuka and Tualang honey
on breast cancer. It was demonstrated a reduction of tumor growth, tumor grading, estrogenic activity,
and hematological parameters. In addition, an increase in the expression of pro-apoptotic proteins,
such as Caspase 9 and p53, and the involvement of some proteins of the inflammation pathway, such
as TNF-α and COX-2 have been demonstrated [72].
Afrin et al. investigated the in vitro effect of Strawberry tree honey (STH) and Manuka honey
against HCT-116, cells of human colon adenocarcinoma, and the LoVo metastatic cell line. They found
an increase in intracellular ROS production, and an antiproliferative effect on both cell lines. A greater
cytotoxic effect has been highlighted for STH, which presented a bigger amount of phytochemicals
and antioxidant properties; these findings demonstrate that the cytotoxic effect of this honey could
be related to the amount of polyphenols present in this matrix [73–75]. Also Jaganathan and Mandal
studied the effect of some types of Indian honeys against colon cancer cell line (HCT-15 and HT-29),
finding a cytotoxic effect of these honeys executed through the cell cycle arrest in subG1 phase and
through the induction of apoptosis [76].
Another study also demonstrated an in vivo anticancer effect on colon cancer in Sprague Dawely
rats injected with N-Nitroso-N-methylurea (NMU), acting primarily on inflammation and oxidative
stress, contrasting the increase in nitric oxide (NO) and malondialdehyde (MDA), which had instead
occurred in animals that had not received the honey-based supplement [77].
Tsiapara et al. studied the effect of three types of Greek honey (thyme, pine, and fir honey)
on prostate cancer cells (PC-3) and endometrial cancer (Ishikawa), showing a reduction in vitality,
and an increase of pro-apoptotic and apoptotic proteins [78]. Similar effects have been demonstrated
on the same prostate cellular line with an Iranian honey. Further studies have been carried out to
identify the compound responsible for this antiproliferative activity, and the chrysin, a flavonoid
widely found in different types of honey, has been identified [79].
In liver cancer cells (HepG2), honey treatment led to the suppression of angiogenesis, induction
of apoptosis and inhibition of cell proliferation [80]. A protective effect of honey has been proven
also in vivo, on rats with diethylnitrosamine (DEN)-induced hepatic cancer, with up-regulation of
p53 [81]. Similar effects have been found also for bladder cancer, both in vitro (T24, RT4, 253J) and
in vivo on mice in which bladder cancer cells (MBT2) were implanted subcutaneously in the abdomens.
The results showed an inhibitory effect on cellular proliferation, and on tumor growth with a reduction
in the final tumor volume in mice treated with honey [82].
The antiproliferative and apoptotic effect of honey, and its polyphenols on human renal cancer
cell lines (ACHN) was investigated, confirming the inhibitory activity of honey on these renal
adenocarcinoma cells [83]. The effects of honey were also investigated for melanoma, both in vitro
and in vivo. Pichichero et al. studied acacia honey’s activity on human melanoma (A375) and
murine (B16-F1) cell lines. In both cases, an antiproliferative effect of honey has been demonstrated,
mainly due to chrysin that mediated the cell cycle arrest in the G0/G1 phase [84]. Regarding in vivo
study, Manuka honey, administered intravenously in mice where murine melanoma tumor cells
(B16F1) were implanted, induced strong proapoptotic activity in a dose and time-dependent manner,
decreasing the final tumor volume. Furthermore, mice in which Manuka honey was given together
with chemotherapy drug (Taxol), had a higher life expectancy compared to those who received only
the chemotherapeutic agent [85]. Ghashm et al. investigated the effects of Tualang honey on oral
squamous cell carcinomas (OSCC) and human osteosarcoma (HOS), confirming its antiproliferative
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and proapoptotic effects on both cell lines [86]. Acacia honey has demonstrated anti-tumor activity in
lung cancer cells (NCI-H460), inhibiting cell proliferation by stopping the cycle in the G0/G1 phase,
stimulating cytokines and downregulating Bcl2 and p53, thus acting as a proapoptotic [87]. Morales,
and Haza studied the effect of three different types of Spanish honeys, two monofloral (Heather and
Rosemary) and one polyfloral in human leukemia cell line (HL-60). Monofloral honeys, particularly
Heather honey, demonstrated a greater cytotoxic effect, mainly due to the induction of apoptosis
through a ROS-independent pathway [88].
5.3. Antidiabetic Effect
There are several evidences that demonstrate a beneficial effect of honey on type 1 and type
2 diabetes mellitus. The measurement of fructosamine, glycosylated hemoglobin, and glucose is
common and fundamental in the practice of glycemic control in patients with diabetes mellitus [89].
Many studies about the effect of honey against diabetes have been performed in vivo in rabbits
and rats. In this context, a diet supplemented with honey was able to reduce glucose concentration in
the serum of diabetic aloxantine-induced rats and streptozotocin (STZ)-induced rats [90]. Regarding
fructosamine and glycosylated hemoglobin, the data are rather limited, although one study has showed
that the combination of honey with some antidiabetic drugs, such as metformin and glibenclamide,
leads to a reduction in glucose serum concentration but also in fructosamine [91].
Clinical studies have revealed that honey consumption, unlike other sweeteners, reduces the
postprandial glycemic response in diabetic and non-diabetic volunteers, lowering the glucose serum
concentration in patients with type 1 and type 2 diabetes [92].
Various evidences attribute the antidiabetic and the hypoglycemic capacity of honey to its
antioxidant ability in relation to its dose; indeed, the pathogenesis of diabetes mellitus, especially type
2, seems to be closely associated with the presence of oxidative stress and ROS in various organs and
tissues [93]. An increase of glucose absorption by adipose tissue and muscles raises ROS production,
contributing to oxidative stress, mechanism that influences the synthesis of glycogen and glucose
uptake. Additionally, oxidative stress can cause insulin resistance through the impairment of insulin
signaling pathway, which can be restored by honey treatment [94]. Even in pancreatic β-cells, oxidative
stress plays an important role, compromising their functionality, with a consequent incorrect insulin
secretion and an increase in apoptosis of β-cells. Generally, it has been proven that the scavenger
activity of honey improves pancreatic oxidative stress [95].
In diabetes mellitus, also lipid metabolism, is compromised, showing a high presence of
low-density lipoproteins (LDLs), which are oxidized and glycated in oxLDLs, leading to endothelial
damages. Even in this case, the antioxidant activity of honey helps to prevent the lipid oxidative
metabolism in patients affects by type 2 diabetes mellitus [96].
5.4. Protective Effects of Honey
5.4.1. Cardiovascular System
Several studies have demonstrated an association between a reduced risk of cardiovascular
disorders and consumption of foods enriched with some compounds also present in honey, such as
flavonoids and vitamin C. The cardioprotective effect of flavonoids has been widely demonstrated,
and it is due to various mechanisms: (i) the reduction of the activity of blood platelets, (ii) the
prevention of oxidation of LDLs, and (iii) the improvement of coronary vasodilatation [97].
The reduction of the activity of blood platelets has been demonstrated in vitro by Ahmed
et al. who have investigated the effects of different types of honey on platelet aggregation and
coagulation. Honey inhibited coagulation through all three coagulation cascades (intrinsic, extrinsic,
and the common cascade) and decreased fibrinogen levels. For all these reasons, honey can be
considered excellent for counteracting the process of atherosclerotic plaques formation that can lead
to the development of cardiac disorders. In the pathogenesis of the atherosclerotic plaques, lipid
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peroxidation also plays a fundamental role [98]. It is confirmed that the honey phenolic compounds
have a preventive and protective effect towards the damaging action of free radicals, counteracting,
as explained, lipid peroxidation [99,100].
5.4.2. Nervous System
Regarding the protective effect of honey in the nervous system, polyphenols play a central role.
The scavenger activity against ROS, which are neurotoxic, and they can counteract various neurologic
pathologies involved in aging. In addition, the deposition of misfolded proteins, such as beta amyloid,
is the basis of some age-related neurological pathologies. Polyphenols are able to counteract this
pathological accumulation [101].
Studies on the anti-hypnotic, anxiolytic, anticonvulsant, and antinociceptive of honey have been
performed on mice and rats, and a real neuropharmacological effect has been demonstrated. In a study
performed by Akanmu et al., the neuropharmacological effects of different types of Nigerian honey
were studied in mice subjected to different behavioral stimuli. The anti-hypnotic effect of honey
was investigated by the oral administration of honey and subsequently pentobarbital, a short-acting
barbiturate. In animals that had received honey, the sleep time was reduced, anxiety was improved,
and convulsions decreased [102]. The antinociceptive effects of different honey samples have been
also demonstrated. Mice that had received an oral administration of honey showed an increase in their
pain thresholds. This analgesic activity of honey is probably mediated by opioid receptors [103].
5.4.3. Respiratory System
Even in popular medicine, honey is commonly utilized as a coughing sedative. Scientific studies
regarding the protective activity of honey in respiratory system mainly concerns asthma. Asthma is
a chronic inflammatory disease that is characterized by generally reversible obstruction of the lower
airways, often as result of activity of allergens [104]. Kamaruzaman et al. have shown that honey
inhalation is able to reduce inflammation of the lower airways in a rabbit model of ovalbumin-induced
chronic asthma. Honey was capable of both preventing and improving the structural changes that
occur following the induction of asthma through the allergen. It is known that honey is also able to
reduce the number of inflammatory cells that are present in the fluid deriving from bronchoalveolar
lavage, also inhibiting the bronchial hyperplasia of the goblet cells [105].
Finally, the role of honey in co-treatment with standard drugs in allergic rhinitis in subjects
recruited from an otolaryngology clinic was investigated. The ingestion of honey in high doses (1 g/kg
body weight daily for four weeks) improved the overall symptoms up to one month after the end of
treatment [106].
5.4.4. Gastrointestinal System
A protective effect on the gastrointestinal system has been also demonstrated. An important
antimicrobial activity against Helicobacter pylori, that is responsible for gastroduodenal ulcers, has
been demonstrated in vitro. The antimicrobial activity of different types of honey has been evaluated
isolating H. pylori from patients with gastric diseases, and its susceptibility to the different types
of honey was evaluated by measuring MIC and MBC. All the examined honeys possessed a high
antibacterial activity with evident therapeutic potential [54].
Clinical studies have similarly shown an improvement in the treatment of infantile gastroenteritis,
with a decrease in the duration of diarrhea, being also useful in the recovery of hydration
post-gastroenteritis [107].
6. Physical Activity, Oxidative Stress, and Honey
A beneficial effect of honey has been shown in athletes, where if a moderate and regular
exercise is able to counteract oxidative stress, an intense and prolonged physical activity can lead to
an over-production of ROS that is often associated with a higher risk of incurring muscular injuries
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and also incurring a decrease in sporting performance [108]. The relationship between oxidative
stress and sport is very complex, because, while dangerous, a release of free radicals is necessary to
stimulate the up-regulation of endogenous antioxidant defenses. In recent years the consumption by
athletes of supplements rich in antioxidant compounds has increased, but a natural contribution of
these compounds through the diet is more recommended [109]. In this context, several studies have
been carried out to explore the effect that honey consumption has in athletes; investigations have been
performed both on murine models and on athletes practicing different sports.
Krisnanda investigated the effect of honey-based supplementation in male Wistar rats (Rattus
norvegicus) subjected to carry out moderate-intensity physical activity (70% of maximum volume
of oxygen VO2 max). After seven days, the value of one of the major markers of oxidative stress,
MDA, was reduced in plasma by 35.52% in the group of rats that received honey (5 g/kg body weight
once a day) [110]. On the other hand, Mosavat et al. studied the effect of eight weeks of honey
supplementation (Tualang honey, 1 g/kg body weight per day) in female rats subjected to jumping
exercise with different intensities on plasma levels of cortisol, which resulted in an increased in rats
subjected to physical exercise compared to sedentary ones, with a lower level in the group subjected to
20 jumps a day compared to 80. Furthermore, in rats that received honey-based supplementation the
increase of stress hormone levels was considerable lower [111].
About studies performed on athletes, the effects of Manuka honey on 32 healthy volunteers
subjected to a short but intense exercise on cycle ergometer were explored. The determination of MDA
levels in serum was performed 10 min before physical exercise and 30 min and 4 h after it. A significant
decrease was noted in subjects who had consumed honey (1 g/kg body weight daily for 1, 2 or 3
weeks) before making physical exertion, with a greater difference for those volunteers who had used it
for three weeks [112].
A very important study was carried out by Tartibian and Maleki, who examined the effects
of honey in 39 road cyclists who participated to eight weeks of intensive cycling training. Some
fundamental markers of oxidative stress (ROS, MDA) and antioxidant defenses (superoxide
dismutase (SOD), catalase (CAT), total antioxidant capacity (TAC)) were examined in seminal fluid.
The measurements were carried out at different times: at baseline and at 12, 24 and 24 h after the last
training session, every four weeks. After four weeks and after eight weeks, ROS and MDA levels were
significantly increased, while SOD, CAT, and TAC levels in the group supplemented with the artificial
sweetener were decreased. In the group that received honey supplementation (70 g), the increase in
markers of oxidative stress was much lower than in the placebo, and the levels of antioxidants were
significantly higher [113]. Ahmad et al. examined the effect of high (1.5 g/kg body weight) and low
doses (0.75 g/kg body weight) of Tualang honey in 20 female athletes that were involved in different
competitive sports; the quantities of total phenolic content (TPC), MDA, and ROS were analyzed,
and the antioxidant activity (ferric reducing antioxidant power (FRAP)) was monitored in the plasma
of these athletes after 30 min, 1, 2 and 3 h after the administration of honey. The results showed that
there was not significant difference between the two different doses and that the greatest antioxidant
capacity was observed in both cases 2 h after the honey intake [114].
7. Infant Botulism and Other Toxic Compounds in Honey
Infant botulism is an acute condition that affects infants (0–1 year). The first report about this
disease was in 1976 in USA. The microorganism Clostridium botulinum, an anaerobic Gram positive
bacillus, is the main organism responsible for infant botulism, principally type A. In infant botulism,
microbial spores are ingested [115], and they find the ideal conditions for the germination in the
colon of children, where bacterial microflora are not yet well developed. Here, the spores germinate
into the vegetative form, and in this phase they are able to produce toxins. From the intestinal tract,
the botulinum neurotoxin reaches neuromuscular plaques via blood, where it works by preventing
the release of acetylcholine, which determine the appearance of clinical symptomatology: descending
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flaccid paralysis that initially affects the musculature of the cranial nerves and can progress to
respiratory arrest [116].
Honey is the most incriminated food as a vehicle for infant botulism. The contamination of honey
can occur either in a beehive, or in the secondary stages of processing. Honey is considered to be one of
the safest foods at a microbiological level, due to its high acidity for the presence of organic acids, and
the low Aw, which is necessary for the survival of microorganisms but not of spores, which manage to
survive even in a hostile environment like honey [117].
Several studies have been carried out to verify the presence of C. Botulinum in honey: for example
a Turkish work [118] analyzed 48 different types of commercial honey, and six of 48 (12.5%) resulted
positive for the presence of C. botulinum spores. Gücükog˘lu et al. have investigated 150 different types
of honey and four of these were positive for the presence of neurotoxins of C. botulinum type A [119];
also in Brazil [120], the presence of spores was investigated in different samples of honey and three of
100 analyzed (3%) were positive; similar results were also obtained by Midura et al., which found nine
honeys out of 90 (10%) [121] and Nevas et al., who analyzed 190 different types of honey and found
that 20 of those were positive for the quiescent form of the microorganism (11%) [122].
There are also other toxic compounds that can be found in honey, which are not naturally present
in it, but they derive from the industrial processes of heating and storage. 5-HMF is a compound
that has been found in some honey samples, especially in those stored for a long time. In fact,
high concentrations of 5-HMF are indicative of honey subjected to overheating or poor storage
conditions, and may indicate that it is an old honey. Furthermore, the analysis of this compound is
also used to monitor a possible adulteration of honey with inverted sugars [123]. This compound
could be mutagenic, carcinogenic, and cytotoxic if taken in high doses [124]; for this reason the Codex
Alimentarius Standard Commission has established a maximum limit for 5-HMF in honey at 40 mg/kg,
with an exception for those of tropical origin (80 mg/kg) [125]. In other studies, it has been seen that
honey can be contaminated with heavy metals such as mercury, cadmium, lead, and arsenic, which are
toxic and carcinogenic [126].
Finally, there are plants that can contain in their nectar toxic substances that are harmful for
human health, such as Rhododendron ponticum or Azalea pontica (honey derived from these plants is
called “Mad honey”) that contain alkaloids, flowers from Andromeda may contain grayanotoxins that
can cause paralysis of the arts [127]. Other toxic compounds found in honey that are derived from
nectar may be hyoscyamine (from Datura sp. [128], hyoscine (from Hyoscamus niger [129], saponin
(from Serjania lethalis [130], strychnine (from Gelsemium sempervirens [131], and others.
8. Conclusions
Honey is a natural product, and a source of amino acids, proteins, enzymes, essential minerals,
vitamins, and bioactive compounds such as phenolic compounds, that possess interesting in vitro
and in vivo biological properties. For example, it is effective in contrasting microbial infection, it has
the potential to hinder malignant cellular proliferation through the modulation of several molecular
pathways. At the same time, its consumption reduces the plasma level of fructosamine, glycosylated
hemoglobin, and glucose in patients with diabetes mellitus, and it ameliorates several risk factors of
cardiovascular disease; it exerts protective effects also in the nervous, respiratory, and gastrointestinal
system. On the other hand, it is important to consider that it may contain some toxic compounds that
should be avoided mainly in childhood. A deeper understanding of the factors and the mechanisms
of honey effect will be of crucial importance to promote the consumption of this healthy food in the
general population, to promote a healthy lifestyle and to prevent the most common pathology.
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